Form 4: Klaviyo Director Roxanne Oulman Reports Equity Changes
Statement of Changes in Beneficial Ownership
Director Roxanne Oulman acquired 14,822 restricted stock units and converted 8,169 shares of Series B common stock to Series A.
Summary
- Director Roxanne Oulman received an award of 14,822 restricted stock units (RSUs) on June 9, 2026.
- The RSUs vest in full on the earlier of June 9, 2027, or the date of the next annual stockholder meeting, contingent on continued board service.
- On June 11, 2026, the director converted 8,169 shares of Series B common stock into an equal number of Series A common stock shares.
- Following these transactions, the director holds 37,343 shares of Series A common stock (including unvested RSUs) and 46,666 shares of Series B common stock held via a GRAT.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director equity holdings with no material impact on company operations.
Positives
- Director alignment with company performance through equity-based compensation.
- Continued long-term commitment to the company through the retention of Series B holdings.
Negatives
- None identified in this filing.
Risks
- Vesting of RSUs is subject to continued service as a member of the board of directors.
Future Outlook
The filing does not provide forward-looking financial guidance, focusing solely on director equity transactions.
Industry Context
StockSavvy.ai notes that director equity grants and conversions are standard corporate governance practices, reflecting typical board compensation structures in the SaaS and technology sector.
Comparison to Industry Standards
- The use of RSUs as a primary vehicle for director compensation is consistent with standard practices for publicly traded technology companies.
- The conversion of super-voting or multi-class shares (Series B) to standard common stock (Series A) is a common administrative action for insiders managing their personal portfolios.
Related Party Transactions
- The reporting person serves as trustee for the Roxanne Oulman 2025 GRAT, which holds 46,666 shares of Series B common stock.
Stakeholder Impact
- Minimal impact on shareholders as these are standard insider equity movements.
Next Steps
- Vesting of RSUs on June 9, 2027, or the next annual meeting.
Key Dates
| Date | Description |
|---|---|
| 06/09/2026 | Grant date of 14,822 restricted stock units. |
| 06/11/2026 | Conversion of 8,169 shares of Series B to Series A common stock. |
| 06/09/2027 | Vesting date for the RSU grant. |
Keywords
Klaviyo, KVYO, Form 4, Insider Trading, Equity Compensation, Director Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.